Case Study

Case Study: National Oncologic Pet Registry

Source: ACR Image Metrix

The National Oncologic PET Registry (NOPR) arose in response to a Centers for Medicare and Medicaid Services (CMS) proposal to expand cancer-related coverage of positron emission tomography (PET) using f-18 fluoro deoxyglucose (FDG). Whereas FDG-PET was CMS-approved for only a limited number of cancers, CMS agreed to conditional coverage of most cancers and related indications for those patients enrolled in a clinical registry evaluating the impact of PET on cancer management. Submitted by ACR Image Metrix

access the Case Study!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests: